These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 29692630)

  • 1. Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation.
    Guo W; Tan HY; Wang N; Wang X; Feng Y
    Cancer Manag Res; 2018; 10():715-734. PubMed ID: 29692630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.
    Wang X; Zhang A; Sun H
    Hepatology; 2013 May; 57(5):2072-7. PubMed ID: 23150189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine.
    Wu X; Wang Z; Luo L; Shu D; Wang K
    Front Med Technol; 2022; 4():1065506. PubMed ID: 36688143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics Identifies Biomarker Pattern for Early Diagnosis of Hepatocellular Carcinoma: from Diethylnitrosamine Treated Rats to Patients.
    Zeng J; Huang X; Zhou L; Tan Y; Hu C; Wang X; Niu J; Wang H; Lin X; Yin P
    Sci Rep; 2015 Nov; 5():16101. PubMed ID: 26526930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status and future prospects of biomarkers in the diagnosis of hepatocellular carcinoma.
    Zhao Y; Gao Q; Pei L; Wang C; Jin L; Liao F
    Int J Biol Markers; 2017 Oct; 32(4):e361-e369. PubMed ID: 28967065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma.
    Luo P; Yin P; Hua R; Tan Y; Li Z; Qiu G; Yin Z; Xie X; Wang X; Chen W; Zhou L; Wang X; Li Y; Chen H; Gao L; Lu X; Wu T; Wang H; Niu J; Xu G
    Hepatology; 2018 Feb; 67(2):662-675. PubMed ID: 28960374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
    Yao M; Zhao J; Lu F
    Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine α-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma.
    Zhan Z; Guan Y; Mew K; Zeng W; Peng M; Hu P; Yang Y; Lu Y; Ren H
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G305-G312. PubMed ID: 31736338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
    Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I
    Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
    Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
    Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative Subtypes.
    Sun J; Zhao Y; Qin L; Li K; Zhao Y; Sun H; Zhang T; Zhang Y
    Front Oncol; 2019; 9():1069. PubMed ID: 31681602
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery.
    Di Poto C; Ferrarini A; Zhao Y; Varghese RS; Tu C; Zuo Y; Wang M; Nezami Ranjbar MR; Luo Y; Zhang C; Desai CS; Shetty K; Tadesse MG; Ressom HW
    Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):675-683. PubMed ID: 27913395
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel analysis method for biomarker identification based on horizontal relationship: identifying potential biomarkers from large-scale hepatocellular carcinoma metabolomics data.
    Su B; Luo P; Yang Z; Yu P; Li Z; Yin P; Zhou L; Fan J; Huang X; Lin X; Qiao Y; Xu G
    Anal Bioanal Chem; 2019 Sep; 411(24):6377-6386. PubMed ID: 31384984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue and serum metabolomic phenotyping for diagnosis and prognosis of hepatocellular carcinoma.
    Han J; Han ML; Xing H; Li ZL; Yuan DY; Wu H; Zhang H; Wang MD; Li C; Liang L; Song YY; Xu AJ; Wu MC; Shen F; Xie Y; Yang T
    Int J Cancer; 2020 Mar; 146(6):1741-1753. PubMed ID: 31361910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease monitoring of hepatocellular carcinoma through metabolomics.
    Fitian AI; Cabrera R
    World J Hepatol; 2017 Jan; 9(1):1-17. PubMed ID: 28105254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
    Sun Y; Mi W; Cai J; Ying W; Liu F; Lu H; Qiao Y; Jia W; Bi X; Lu N; Liu S; Qian X; Zhao X
    J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
    Parizadeh SM; Jafarzadeh-Esfehani R; Ghandehari M; Goldani F; Parizadeh SMR; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Avan A
    Curr Drug Targets; 2019; 20(11):1129-1140. PubMed ID: 30848198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma.
    Wang T; Zhang KH
    Front Oncol; 2020; 10():1316. PubMed ID: 32923383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the early diagnosis of hepatocellular carcinoma.
    Wang W; Wei C
    Genes Dis; 2020 Sep; 7(3):308-319. PubMed ID: 32884985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urea as a By-Product of Ammonia Metabolism Can Be a Potential Serum Biomarker of Hepatocellular Carcinoma.
    Bai C; Wang H; Dong D; Li T; Yu Z; Guo J; Zhou W; Li D; Yan R; Wang L; Wang Z; Li Y; Ren L
    Front Cell Dev Biol; 2021; 9():650748. PubMed ID: 33869206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.